Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1032692.RAsOmk7sy4U-BOSC9ML_2LqXPLfi9aHM3mX68N9r_FHw0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1032692.RAsOmk7sy4U-BOSC9ML_2LqXPLfi9aHM3mX68N9r_FHw0130_assertion type Assertion NP1032692.RAsOmk7sy4U-BOSC9ML_2LqXPLfi9aHM3mX68N9r_FHw0130_head.
- NP1032692.RAsOmk7sy4U-BOSC9ML_2LqXPLfi9aHM3mX68N9r_FHw0130_assertion description "[Moreover, when concomitantly expressed with oncogenic Kras, Sox9 accelerates formation of premalignant lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1032692.RAsOmk7sy4U-BOSC9ML_2LqXPLfi9aHM3mX68N9r_FHw0130_provenance.
- NP1032692.RAsOmk7sy4U-BOSC9ML_2LqXPLfi9aHM3mX68N9r_FHw0130_assertion evidence source_evidence_literature NP1032692.RAsOmk7sy4U-BOSC9ML_2LqXPLfi9aHM3mX68N9r_FHw0130_provenance.
- NP1032692.RAsOmk7sy4U-BOSC9ML_2LqXPLfi9aHM3mX68N9r_FHw0130_assertion SIO_000772 23201164 NP1032692.RAsOmk7sy4U-BOSC9ML_2LqXPLfi9aHM3mX68N9r_FHw0130_provenance.
- NP1032692.RAsOmk7sy4U-BOSC9ML_2LqXPLfi9aHM3mX68N9r_FHw0130_assertion wasDerivedFrom befree-2016 NP1032692.RAsOmk7sy4U-BOSC9ML_2LqXPLfi9aHM3mX68N9r_FHw0130_provenance.
- NP1032692.RAsOmk7sy4U-BOSC9ML_2LqXPLfi9aHM3mX68N9r_FHw0130_assertion wasGeneratedBy ECO_0000203 NP1032692.RAsOmk7sy4U-BOSC9ML_2LqXPLfi9aHM3mX68N9r_FHw0130_provenance.